256 related articles for article (PubMed ID: 28353307)
1. Prediction of unstable anticoagulation with acenocoumarol versus warfarin in atrial fibrillation.
Bryk AH; Plens K; Undas A
Cardiol J; 2017; 24(5):477-483. PubMed ID: 28353307
[TBL] [Abstract][Full Text] [Related]
2. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
[TBL] [Abstract][Full Text] [Related]
3. Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.
Williams BA; Evans MA; Honushefsky AM; Berger PB
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025746
[TBL] [Abstract][Full Text] [Related]
4. Modified application of SAMe-TT2R2 scoring system in Asian patients with atrial fibrillation for the selection of oral anticoagulants.
Jeon SW; Lee N; Lee KH; Ha M; Kim C; Kim YR; Yoon NS; Park HW
Korean J Intern Med; 2024 May; 39(3):458-468. PubMed ID: 38287499
[TBL] [Abstract][Full Text] [Related]
5. Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence.
Chan PH; Hai JJ; Chan EW; Li WH; Tse HF; Wong IC; Lip GY; Siu CW
PLoS One; 2016; 11(3):e0150674. PubMed ID: 27010633
[TBL] [Abstract][Full Text] [Related]
6. Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists.
Ruiz-Ortiz M; Bertomeu V; Cequier Á; Marín F; Anguita M
Thromb Haemost; 2015 Oct; 114(4):695-701. PubMed ID: 26054407
[TBL] [Abstract][Full Text] [Related]
7. Prediction Score for Anticoagulation Control Quality Among Older Adults.
Lin KJ; Singer DE; Glynn RJ; Blackley S; Zhou L; Liu J; Dube G; Oertel LB; Schneeweiss S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982676
[TBL] [Abstract][Full Text] [Related]
8. SAMe-TT
Kataruka A; Kong X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Krol GD; Kaatz S; McNamara MW; Froehlich JB; Barnes GD
Vasc Med; 2017 Jun; 22(3):197-203. PubMed ID: 28145152
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists.
Abumuaileq RR; Abu-Assi E; Raposeiras-Roubin S; López-López A; Redondo-Diéguez A; Álvarez-Iglesias D; Rodríguez-Mañero M; Peña-Gil C; González-Juanatey JR
Europace; 2015 May; 17(5):711-7. PubMed ID: 25662984
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of SAMe-TT
Hwang AY; Carris NW; Dietrich EA; Gums JG; Smith SM
Ann Pharmacother; 2018 Nov; 52(11):1085-1090. PubMed ID: 29857777
[TBL] [Abstract][Full Text] [Related]
11. The Sex, Age, Medical History, Treatment, Tobacco Use, Race Risk (SAMe TT
Bernaitis N; Ching CK; Chen L; Hon JS; Teo SC; Davey AK; Anoopkumar-Dukie S
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):64-69. PubMed ID: 27671097
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation.
Korenstra J; Wijtvliet EP; Veeger NJ; Geluk CA; Bartels GL; Posma JL; Piersma-Wichers M; Van Gelder IC; Rienstra M; Tieleman RG
Europace; 2016 Sep; 18(9):1319-27. PubMed ID: 26843571
[TBL] [Abstract][Full Text] [Related]
14. Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials.
Proietti M; Lane DA; Lip GY
Int J Cardiol; 2016 Aug; 216():168-72. PubMed ID: 27156060
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
Lip GYH; Lane DA; Buller H; Apostolakis S
Chest; 2013 Dec; 144(6):1839-1847. PubMed ID: 24009027
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of SAMe-TT2R2 score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in Spain.
Lobos-Bejarano JM; Barrios V; Polo-García J; Escobar C; Vargas-Ortega D; Marín-Montañés N; Prieto-Valiente L; Fuentes S; Prieto MA; García-Ortiz L;
Curr Med Res Opin; 2016 Jul; 32(7):1201-7. PubMed ID: 26967541
[TBL] [Abstract][Full Text] [Related]
17. Integrating genotypes in the SAMe-TT
Liu J; Wang N; Qin L; Liu J; Xi S; Wang X; Li X; Zhang Y; Yin T
Int J Cardiol; 2017 Aug; 241():358-363. PubMed ID: 28479094
[TBL] [Abstract][Full Text] [Related]
18. SAMe-TT2R2 Score in the Outpatient Anticoagulation Clinic to Predict Time in Therapeutic Range and Adverse Events.
Pivatto Junior F; Scheffel RS; Ries L; Wolkind RR; Marobin R; Barkan SS; Amon LC; Biolo A
Arq Bras Cardiol; 2017 Apr; 108(4):290-296. PubMed ID: 28538758
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea.
Szymanski FM; Lip GY; Filipiak KJ; Platek AE; Karpinski G
Int J Cardiol; 2016 Feb; 204():200-5. PubMed ID: 26670173
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists.
Demelo-Rodríguez P; Postigo-Esteban A; García-Fernández-Bravo I; Agud M; Calpena S; Camacho M; Del Toro-Cervera J
Thromb Res; 2016 Nov; 147():58-60. PubMed ID: 27676254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
